FIELD: medicine.
SUBSTANCE: claimed is application of solid peroral dosing composition of prolonged action, which includes (a) core, containing effective amount of pseudoephedrine or its salt, (b) first envelope, covering core and including swelling in water film-forming neutral or cationogenic copolymer ester, film modifier and lubricating substance, and (c) second envelope, covering first envelope and including effective amount of desloratadine, amount of pseudoephedrine or its salt is sufficient for ensuring maximaum of average geometrical values of pseudoephedrine concentration in plasma, from 345 to 365 ng/ml, for the time from 7.60 to 8.40 h, and amount of desloratadine is sufficient for ensuring maximum of its average geometrical values of concentration in plasma, from 2.10 to 2.45 ng/ml, for period from 4.0 to 4.5 h after intake of single dose of said composition, for preparation of medication for treatment of allergic and/or inflammatory states of upper and lower respiratory ways and skin, or urticaria and nasal and non-nasal symptoms of year-round and seasonal allergic rhinitis.
EFFECT: composition ensures necessary profile of active agents release and is efficient in treatment of allergic bronchospasm, couphing, seasonal allergic rhinites.
3 cl, 4 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
STABLE ORAL DOSED SUSTAINED-RELEASE COMPOSITION | 2000 |
|
RU2303440C2 |
PERORAL DOSED COMPOSITION OF PROLONGED ACTION | 2000 |
|
RU2284182C9 |
TABLET CONTAINING CETIRIZINE AND PSEUDOEPHEDRINE | 2002 |
|
RU2286784C2 |
PHARMACEUTICAL DOSAGE FORMS AND COMPOSITIONS OF COLON ABSORBED PHENYLEPHRINE | 2007 |
|
RU2454225C2 |
PHARMACEUTICAL COMPOSITIONS CONTAINING CONJUGATED ESTROGENS AND BAZEDOXIFENE | 2006 |
|
RU2395286C2 |
HARD, SUITABLE FOR ORAL INTAKE PHARMACEUTICAL FORMS OF APPLICATION, CONTAINING RIVAROXABAN WITH MODIFIED RELEASE | 2005 |
|
RU2420290C2 |
PROLONGED PHARMACEUTICAL COMPOSITION DRUG FORM AND METHOD OF ITS PRODUCTION (VERSIONS) | 2009 |
|
RU2435584C2 |
COMPOSITIONS OF ORALLY DISPERSIBLE TABLETS CONTAINING COMBINATIONS OF HIGH- AND LOW-DOSE THERAPEUTIC AGENTS | 2010 |
|
RU2554740C2 |
MATRIX TABLET WITH BASIS FOR TRIMETAZIDINE DIHYDROCHLORIDE RELEASE, WAY OF ITS RECEPTION AND WAY OF TREATMENT | 2007 |
|
RU2362548C1 |
SUGAR COATINGS AND METHODS OF THEIR APPLICATION | 2005 |
|
RU2428178C2 |
Authors
Dates
2011-07-10—Published
2007-02-02—Filed